Endoscopy 2018; 50(10): 961-971
DOI: 10.1055/a-0620-8135
Original article
© Georg Thieme Verlag KG Stuttgart · New York

Fully vs. partially covered selfexpandable metal stent for palliation of malignant esophageal strictures: a randomized trial (the COPAC study)

Paul Didden
1  Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands
,
Agnes N. Reijm
1  Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands
,
Nicole S. Erler
2  Department of Biostatistics, Erasmus University Medical Center, Rotterdam, The Netherlands
,
Leonieke M. M. Wolters
3  Department of Gastroenterology and Hepatology, Albert Schweitzer Hospital, Dordrecht, The Netherlands
,
Thjon J. Tang
4  Department of Gastroenterology and Hepatology, IJsselland Hospital, Capelle aan den Ijssel, The Netherlands
,
Pieter C. J. ter Borg
5  Department of Gastroenterology and Hepatology, Ikazia Hospital, Rotterdam, The Netherlands
,
Ivonne Leeuwenburgh
6  Department of Gastroenterology and Hepatology, Fransiscus Hospital, Rotterdam, The Netherlands
,
Marco J. Bruno
1  Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands
,
Manon C. W. Spaander
1  Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands
› Author Affiliations
TRIAL REGISTRATION: Interventional study NCT01661686at clinicaltrials.gov
Further Information

Publication History

submitted 23 October 2017

accepted after revision 23 March 2018

Publication Date:
12 June 2018 (eFirst)

Abstract

Background Covered esophageal self-expandable metal stents (SEMSs) are currently used for palliation of malignant dysphagia. The optimal extent of the covering to prevent recurrent obstruction is unknown. Therefore, we aimed to compare fully covered (FC) versus partially covered (PC) SEMSs in patients with incurable malignant esophageal stenosis.

Methods In this multicenter randomized controlled trial, 98 incurable patients with dysphagia caused by a malignant stricture of the esophagus or cardia were randomized 1:1 to an FC-SEMS or PC-SEMS. The primary outcome was recurrent obstruction after endoscopic SEMS placement. Secondary outcomes were technical and clinical success, adverse events, and health-related quality of life (HRQoL). Patients were followed until 6 months after SEMS placement or to SEMS removal, second SEMS insertion, or death, whichever came first.

Results Recurrent obstruction after SEMS placement was similar for both types of stents: 19 % for FC-SEMSs and 22 % for PC-SEMSs (P = 0.65). The times to recurrent obstruction did not differ. The frequency of adverse events was similar between the two groups, with major adverse events occurring in 38 % and 47 % of patients for FC-SEMSs and PC-SEMSs, respectively (P = 0.34). No significant differences were seen in technical success, improvement of dysphagia, and HRQoL. Proximal esophageal stenosis and female sex were independently associated with recurrent obstruction and/or major adverse events.

Conclusions Esophageal FC-SEMSs did not reveal a lower recurrent obstruction rate compared with PC-SEMSs in the palliative management of malignant dysphagia.

Table e5 and Fig. e6